| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, February 2007, p. 1511-1516, Vol. 81, No. 3
0022-538X/07/$08.00+0 doi:10.1128/JVI.01816-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Microbiología II, Fac Farmacia, UCM, Madrid, Spain,1 Cancer Research-UK Laboratories and Department of Oncology, Imperial College London, London, United Kingdom2
Received 21 August 2006/ Accepted 5 November 2006
The Kaposi's sarcoma-associated herpesvirus latent protein LANA2 has been suggested to have an important role in the transforming activity of the virus based on its capacity to inhibit p53 and PKR-dependent apoptosis as well as the interferon-dependent response. Here, we describe a novel interaction between LANA2 and both the phosphoserine/phosphothreonine-binding 14-3-3 proteins and the transcription factor FOXO3a. In addition, our results indicate that LANA2 inhibits the transcriptional activity of FOXO3a and blocks the G2/M arrest induced by 14-3-3 protein overexpression. These results suggest a novel mechanism by which LANA2 may promote tumorigenesis.
Published ahead of print on 15 November 2006.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|